Get started
WANJIA ASSET MANAGEMENT CO LTD HK CONNECT INNOVATIVE DRUG ETF CNYWANJIA ASSET MANAGEMENT CO LTD HK CONNECT INNOVATIVE DRUG ETF CNYWANJIA ASSET MANAGEMENT CO LTD HK CONNECT INNOVATIVE DRUG ETF CNY

WANJIA ASSET MANAGEMENT CO LTD HK CONNECT INNOVATIVE DRUG ETF CNY

No trades
See on Supercharts
Overview
Analysis
Holdings Discussions Technicals Seasonals

Key stats


Assets under management (AUM)
‪229.85 M‬ CNY
Fund flows (1Y)
‪12.78 M‬ CNY
Dividend yield (indicated)
—
Discount/Premium to NAV
1.0%
Shares outstanding
‪204.08 M‬
Expense ratio
—

About WANJIA ASSET MANAGEMENT CO LTD HK CONNECT INNOVATIVE DRUG ETF CNY


Issuer
Wanjia Fund Management Co Ltd.
Brand
Wanjia
Home page
wjasset.com
Inception date
Sep 13, 2024
Structure
Open-Ended Fund
Index tracked
CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net
Replication method
Physical
Management style
Passive
Dividend treatment
Distributes
Primary advisor
Wanjia Asset Management Co., Ltd.
ISIN
CNE100006LT9

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharmaceuticals
Strategy
Vanilla
Geography
Hong Kong
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance——————
NAV total return——————

What's in the fund


As of December 31, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks93.67%
Health Technology92.34%
Commercial Services1.33%
Bonds, Cash & Other6.33%
Cash4.85%
Miscellaneous1.48%
Stock breakdown by region
9%90%
Asia90.29%
North America9.71%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows